BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 26541276)

  • 21. Protective effects of COX-2 inhibitor on titanium-particle-induced inflammatory osteolysis via the down-regulation of RANK/RANKL.
    Geng D; Mao H; Wang J; Zhu X; Huang C; Chen L; Yang H; Xu Y
    Acta Biomater; 2011 Aug; 7(8):3216-21. PubMed ID: 21601661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The cross-talk between osteoclasts and osteoblasts in response to strontium treatment: involvement of osteoprotegerin.
    Peng S; Liu XS; Huang S; Li Z; Pan H; Zhen W; Luk KD; Guo XE; Lu WW
    Bone; 2011 Dec; 49(6):1290-8. PubMed ID: 21925296
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Erythromycin inhibits wear debris-induced osteoclastogenesis by modulation of murine macrophage NF-kappaB activity.
    Ren W; Li XH; Chen BD; Wooley PH
    J Orthop Res; 2004 Jan; 22(1):21-9. PubMed ID: 14656655
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Interleukin-4 and osteoprotegerin suppress polyethylene wear debris-induced osteolysis in a murine air pouch model].
    Wang Y; Zhou R; Wu NN; Mou YQ; Li RD; Deng ZL
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Oct; 31(10):1709-13. PubMed ID: 22027773
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cepharanthine ameliorates titanium particle-induced osteolysis by inhibiting osteoclastogenesis and modulating OPG/RANKL ratio in a murine model.
    Liao L; Lin Y; Liu Q; Zhang Z; Hong Y; Ni J; Yu S; Zhong Y
    Biochem Biophys Res Commun; 2019 Sep; 517(3):407-412. PubMed ID: 31376931
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unfractionated Heparin Promotes Osteoclast Formation in Vitro by Inhibiting Osteoprotegerin Activity.
    Li B; Lu D; Chen Y; Zhao M; Zuo L
    Int J Mol Sci; 2016 Apr; 17(4):. PubMed ID: 27110777
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MMP-9 inhibition suppresses wear debris-induced inflammatory osteolysis through downregulation of RANK/RANKL in a murine osteolysis model.
    Chen D; Zhang X; Guo Y; Shi S; Mao X; Pan X; Cheng T
    Int J Mol Med; 2012 Dec; 30(6):1417-23. PubMed ID: 23027468
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adenovirus-mediated expression of bone morphogenetic protein-2 activates titanium particle-induced osteoclastogenesis and this effect occurs in spite of the suppression of TNF-α expression by siRNA.
    Sun S; Guo H; Zhang J; Yu B; Sun K; Jin Q
    Int J Mol Med; 2013 Aug; 32(2):403-9. PubMed ID: 23708523
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sesquiterpene lactone parthenolide blocks lipopolysaccharide-induced osteolysis through the suppression of NF-kappaB activity.
    Yip KH; Zheng MH; Feng HT; Steer JH; Joyce DA; Xu J
    J Bone Miner Res; 2004 Nov; 19(11):1905-16. PubMed ID: 15476591
    [TBL] [Abstract][Full Text] [Related]  

  • 30. RANKL targeted peptides inhibit osteoclastogenesis and attenuate adjuvant induced arthritis by inhibiting NF-κB activation and down regulating inflammatory cytokines.
    Naidu VG; Dinesh Babu KR; Thwin MM; Satish RL; Kumar PV; Gopalakrishnakone P
    Chem Biol Interact; 2013 Apr; 203(2):467-79. PubMed ID: 23333834
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endoplasmic reticulum stress-mediated inflammatory signaling pathways within the osteolytic periosteum and interface membrane in particle-induced osteolysis.
    Liu G; Liu N; Xu Y; Ti Y; Chen J; Chen J; Zhang J; Zhao J
    Cell Tissue Res; 2016 Feb; 363(2):427-47. PubMed ID: 26004143
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene expression relevant to osteoclastogenesis in the synovium and bone marrow of mature rats with collagen-induced arthritis.
    Kishimoto Y; Fukumoto S; Nishihara S; Mizumura H; Hirai K; Teshima R
    Rheumatology (Oxford); 2004 Dec; 43(12):1496-503. PubMed ID: 15353610
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Icariin inhibits osteoclast differentiation and bone resorption by suppression of MAPKs/NF-κB regulated HIF-1α and PGE(2) synthesis.
    Hsieh TP; Sheu SY; Sun JS; Chen MH
    Phytomedicine; 2011 Jan; 18(2-3):176-85. PubMed ID: 20554188
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of tumor necrosis factor α on ability of SHED to promote osteoclastogenesis during physiological root resorption.
    Wang C; Wang Y; Liu N; Cai C; Xu L
    Biomed Pharmacother; 2019 Jun; 114():108803. PubMed ID: 30951949
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Curculigoside Protects against Titanium Particle-Induced Osteolysis through the Enhancement of Osteoblast Differentiation and Reduction of Osteoclast Formation.
    Zhu F; Wang J; Ni Y; Yin W; Hou Q; Zhang Y; Yan S; Quan R
    J Immunol Res; 2021; 2021():5707242. PubMed ID: 34285923
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Erythromycin inhibits wear debris-induced inflammatory osteolysis in a murine model.
    Ren W; Wu B; Peng X; Mayton L; Yu D; Ren J; Chen BD; Wooley PH
    J Orthop Res; 2006 Feb; 24(2):280-90. PubMed ID: 16435361
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MiR-377 inhibits wear particle-induced osteolysis via targeting RANKL.
    Li W; Wang X; Chang L; Wang F
    Cell Biol Int; 2019 Jun; 43(6):658-668. PubMed ID: 30958621
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation.
    Quinn JM; Horwood NJ; Elliott J; Gillespie MT; Martin TJ
    J Bone Miner Res; 2000 Aug; 15(8):1459-66. PubMed ID: 10934644
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of disease-modifying antirheumatic drugs and antiinflammatory cytokines on human osteoclastogenesis through interaction with receptor activator of nuclear factor kappaB, osteoprotegerin, and receptor activator of nuclear factor kappaB ligand.
    Lee CK; Lee EY; Chung SM; Mun SH; Yoo B; Moon HB
    Arthritis Rheum; 2004 Dec; 50(12):3831-43. PubMed ID: 15593184
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of Erigeron Breviscapus on the expression of OPG/RANKL/RANK in osteoblasts and pre-osteoclasts in vitro].
    Liu CG; Luo QX; Ling TY; Mo YY; Cheng ZL; Huang SG; Mo H
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Dec; 33(12):1658-64. PubMed ID: 24517065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.